Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Moosig

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Zeitschrift Fur Rheumatologie|September 7, 2021
Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2/COVID-19 pandemic, including recommendations for COVID-19 vaccinationChristof Specker, Peer Aries, Jürgen Braun, et al.
Plos One|November 20, 2014
A candidate gene approach identifies an IL33 genetic variant as a novel genetic risk factor for GCAAna Márquez, Roser Solans, José Hernández-Rodríguez, et al.
The Journal of Rheumatology|September 22, 2023
Cluster Analysis to Explore Clinical Subphenotypes of Eosinophilic Granulomatosis With PolyangiitisEmma Rubenstein, Carla Maldini, Augusto Vaglio, et al.
American Journal of Respiratory and Critical Care Medicine|June 26, 2020
International Consensus on ANCA Testing in Eosinophilic Granulomatosis with PolyangiitisSergey Moiseev, Xavier Bossuyt, Yoshihiro Arimura, et al.
Nature Reviews. Rheumatology|May 10, 2023
Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitisGiacomo Emmi, Alessandra Bettiol, Elena Gelain, et al.
Nature Communications|November 14, 2019
Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA statusPaul A Lyons, James E Peters, Federico Alberici, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 4, 2021
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational StudyAlessandra Bettiol, Maria Letizia Urban, Lorenzo Dagna, et al.
Journal of Autoimmunity|March 27, 2025
Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative studyIrene Mattioli, Maria Letizia Urban, Roberto Padoan, et al.
American Journal of Human Genetics|March 31, 2015
A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibilityF David Carmona, Sarah L Mackie, Jose-Ezequiel Martín, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Zeitschrift Fur Rheumatologie|September 7, 2021
Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2/COVID-19 pandemic, including recommendations for COVID-19 vaccinationChristof Specker, Peer Aries, Jürgen Braun, et al.
Plos One|November 20, 2014
A candidate gene approach identifies an IL33 genetic variant as a novel genetic risk factor for GCAAna Márquez, Roser Solans, José Hernández-Rodríguez, et al.
The Journal of Rheumatology|September 22, 2023
Cluster Analysis to Explore Clinical Subphenotypes of Eosinophilic Granulomatosis With PolyangiitisEmma Rubenstein, Carla Maldini, Augusto Vaglio, et al.
American Journal of Respiratory and Critical Care Medicine|June 26, 2020
International Consensus on ANCA Testing in Eosinophilic Granulomatosis with PolyangiitisSergey Moiseev, Xavier Bossuyt, Yoshihiro Arimura, et al.
Nature Reviews. Rheumatology|May 10, 2023
Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitisGiacomo Emmi, Alessandra Bettiol, Elena Gelain, et al.
Nature Communications|November 14, 2019
Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA statusPaul A Lyons, James E Peters, Federico Alberici, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 4, 2021
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational StudyAlessandra Bettiol, Maria Letizia Urban, Lorenzo Dagna, et al.
Journal of Autoimmunity|March 27, 2025
Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative studyIrene Mattioli, Maria Letizia Urban, Roberto Padoan, et al.
American Journal of Human Genetics|March 31, 2015
A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibilityF David Carmona, Sarah L Mackie, Jose-Ezequiel Martín, et al.
Pageof 8